Showing 1 - 10 of 10
Persistent link: https://www.econbiz.de/10014474188
Opioid overdose deaths in older adults have increased substantially over the past two decades. This increase has occurred despite the availability of effective treatments. Methadone, one of just three medications approved by the Food & Drug Administration for opioid use disorder (OUD) treatment,...
Persistent link: https://www.econbiz.de/10014437015
Persistent link: https://www.econbiz.de/10012627520
We studied the effect of marijuana liberalization policies on perinatal health with a multiperiod difference-in-differences estimator that exploited variation in effective dates of medical marijuana laws (MML) and recreational marijuana laws (RML). We found that the proportion of maternal...
Persistent link: https://www.econbiz.de/10012629516
A large concern in U.S. opioid policy is whether supply side controls are effective at reducing the quantity of opioids prescribed, without harmful substitution. An unstudied way that policy targeted a major opioid through the federal Controlled Substance Act (CSA) was the August 2014 scheduling...
Persistent link: https://www.econbiz.de/10012826652
Persistent link: https://www.econbiz.de/10012395684
Persistent link: https://www.econbiz.de/10012055901
Persistent link: https://www.econbiz.de/10012264020
Drug control policy can have unintended consequences by pushing existing users to alternative, possibly more dangerous substances. Policies that target only new users may therefore be especially promising. Using commercial insurance claims data, we provide the first evidence on a set of new...
Persistent link: https://www.econbiz.de/10012867907
Opioid use is one of the most substantial and long-lasting public health crises faced by the United States. This crisis, which began by the mid-1990s and continues through the time of writing, causes 136 fatal opioid overdoses each day and costs the U.S. at least $596 billion each year. These...
Persistent link: https://www.econbiz.de/10013191077